Basic fibroblast growth factor (bFGF) and its receptor expression (bek and flg) In bone marrow stroma of murine AIDS

Virus Research

Volumn 101, Issue 2, 2004, Pages 175-184

  Tse, Kam Fai ^a,b   Inayat, Mohammed S ^a   Morrow, Jennifer K ^a   Dellapuca, Richard ^a   Hughes, Nedda K ^a   Gallicchio, Vincent S ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

bFGF; Receptor expression; Stromal cells; Virus infection

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; CELL SURFACE RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE MARROW CULTURE; BONE MARROW DEPRESSION; CELL LINEAGE; CELL STIMULATION; CONTROLLED STUDY; CYTOPENIA; GENE EXPRESSION; HEMATOPOIESIS; IMMUNOFLUORESCENCE; IN VITRO STUDY; LYMPHOMA; MICROENVIRONMENT; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RODENT DISEASE; STEM CELL; STROMA; STROMA CELL; VIRUS INFECTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BONE MARROW CELLS; CELL LINE; COLONY-FORMING UNITS ASSAY; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; HEMATOPOIETIC STEM CELLS; LEUKEMIA VIRUS, MURINE; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; MURINE ACQUIRED IMMUNODEFICIENCY SYNDROME; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RECEPTORS, FIBROBLAST GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STROMAL CELLS; TRANSCRIPTION, GENETIC;

MURINAE;

EID: 1642388481     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2004.01.007     Document Type: Article

References (43)

1. Aoki Y., Tosato G. Targeted inhibition of angiogenic factors in AIDS-related disorders. Curr. Dryg. Targets Infect. Disord. 3:2003;115.
2. Aziz D.C., Hanna Z., Jolicoeur P. Severe immunodeficiency disease induced by a defective murine leukaemia virus. Nature. 338:1989;505.
3. Chattopadhyay S.K., Morse H.C. III, Makino M., Ruscetti S.K., Hartley J.W. Defective virus is associated with induction of murine retrovirus-induced immunodeficiency syndrome. Proc. Natl. Acad. Sci. USA. 86:1989;3862.
4. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156.
5. Cosic I., Drummond A.E., Underwood J.R., Hearn M.T. In vitro inhibition of the actions of basic FGF by a novel 16 amino acid peptide. Mol. Cell Biochem. 130:1994;1.
6. Coyle T.E. Hematologic complications of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Med. Clin. North Am. 81:1997;449.
7. Dionne C.A., Crumley G., Bellot F., Kaplow J.M., Searfoss G., Ruta M., Burgess W.H., Jaye M., Schlessinger J. Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors. Embo J. 9:1990;2685.
8. Donahue R.E., Johnson M.M., Zon L.I., Clark S.C., Groopman J.E. Suppression of in vitro haematopoiesis following human immunodeficiency virus infection. Nature. 326:1987;200.
9. Gabbianelli M., Sargiacomo M., Pelosi E., Testa U., Isacchi G., Peschle C. "Pure" human hematopoietic progenitors: permissive action of basic fibroblast growth factor. Science. 249:1990;1561.
10. Gabrilove J.L., Wong G., Bollenbacher E., White K., Kojima S., Wilson E.L. Basic fibroblast growth factor counteracts the suppressive effect of transforming growth factor-beta 1 on human myeloid progenitor cells. Blood. 81:1993;909.
11. Gabrilove J.L., White K., Rahman Z., Wilson E.L. Stem cell factor and basic fibroblast growth factor are synergistic in augmenting committed myeloid progenitor cell growth. Blood. 83:1994;907.
12. Gallicchio V.S., Hughes N.K., Hulette B.C., DellaPuca R., Noblitt L. Basic fibroblast growth factor (B-FGF) induces early (CFU-s) and late-stage hematopoietic progenitor cell colony formation (CFU-GM, CFU-Meg, and BFU-E) by synergizing with GM-CSF, Meg-CSF, and erythropoietin, and is a radioprotective agent in vitro. Int. J. Cell Cloning. 9:1991;220.
13. Gallicchio V.S., Tse K.F., Morrow J., Hughes N.K. Suppression of hematopoietic support function is associated with overexpression of interleukin-4 and transforming growth factor-beta 1 in LP-BM5 murine-leukemia-virus-infected stromal cell lines. Acta. Haematol. 95:1996;204.
14. Geissler R.G., Ottmann O.G., Kleiner K., Mentzel U., Bickelhaupt A., Hoelzer D., Ganser A. Decreased haematopoietic colony growth in long-term bone marrow cultures of HIV-positive patients. Res. Virol. 144:1993;69.
15. Gill V., Shattock R.J., Scopes J., Hayes P., Freedman A.R., Griffin G.E., Gordon-Smith E.C., Gibson F.M. Human immunodeficiency virus infection impairs hemopoiesis in long-term bone marrow cultures: non-reversal by nucleoside analogues. J. Infect. Dis. 176:1997;1510.
16. Glatt A.E., Chirgwin K., Landesman S.H. Current concepts. Treatment of infections associated with human immunodeficiency virus. N. Engl. J. Med. 318:1988;1439.
17. Hamburger A.W., Chen R.B. Impaired ability of bone marrow cells from immunodeficient mice to establish long-term cultures. Br. J. Haematol. 85:1993;646.
18. Johnson M., Caiazzo T., Molina J.M., Donahue R., Groopman J. Inhibition of bone marrow myelopoiesis and erythropoiesis in vitro by anti-retroviral nucleoside derivatives. Br. J. Haematol. 70:1988;137.
19. Li J.M., Shen X., Hu P.P., Wang X.F. Transforming growth factor beta stimulates the human immunodeficiency virus 1 enhancer and requires NF-kappaB activity. Mol. Cell. Biol. 18:1998;110.
20. Lobato Da Silva C., Goncalves R., Lemos F., Lemos M.A., Zanjani E.D., Almeda-Porada G., Cabral J.M. Modelling of ex vivo expansion/maintenance of hematopoietic stem cells. Bioprocess Biosyst Eng. 25:2003;365.
21. Mosier D.E. Animal models for retrovirus-induced immunodeficiency disease. Immunol. Invest. 15:1986;233.
22. Mosier D.E., Yetter R.A., Morse H.C. III Functional T lymphocytes are required for a murine retrovirus-induced immunodeficiency disease (MAIDS). J. Exp. Med. 165:1987;1737.
23. Murphy M.F., Metcalfe P., Waters A.H., Carne C.A., Weller I.V., Linch D.C., Smith A. Incidence and mechanism of neutropenia and thrombocytopenia in patients with human immunodeficiency virus infection. Br. J. Haematol. 66:1987;337.
24. Neufeld G., Gospodarowicz D. Basic and acidic fibroblast growth factors interact with the same cell surface receptors. J. Biol. Chem. 261:1986;5631.
25. Neufeld G., Gospodarowicz D. Protamine sulfate inhibits mitogenic activities of the extracellular matrix and fibroblast growth factor, but potentiates that of epidermal growth factor. J. Cell Physiol. 132:1987;287.
26. Ogata N., Day N.K., Buell R.D., Good R.A., Bradley W.G. Detection of the MAIDS virus using the polymerase chain reaction. PCR Methods Appl. 2:1993;272.
27. Oliver L.J., Rifkin D.B., Gabrilove J., Hannocks M.J., Wilson E.L. Long-term culture of human bone marrow stromal cells in the presence of basic fibroblast growth factor. Growth Factors. 3:1990;231.
28. Rappolee D.A., Wang A., Mark D., Werb Z. Novel method for studying mRNA phenotypes in single or small numbers of cells. J. Cell Biochem. 39:1989;1.
29. Rifkin D.B., Moscatelli D. Recent developments in the cell biology of basic fibroblast growth factor. J. Cell. Biol. 109:1989;1.
30. Sgadari C., Barillari G., Toschi E., Carlei D., Bacigalupo I., Baccarini S., Palladino C., Leone P., Bugarini R., Malavasi L., Cafaro A., Falchi M., Valdembri D., Rezza G., Bussolino F., Monini P., Ensoli B. HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma. Nat. Med. 8:2003;225.
31. Schneider D.R., Picker L.J. Myelodysplasia in the acquired immune deficiency syndrome. Am. J. Clin. Pathol. 84:1985;144.
32. Sing G.K., Keller J.R., Ellingsworth L.R., Ruscetti F.W. Transforming growth factor-beta 1 enhances the suppression of human hematopoiesis by tumor necrosis factor-alpha or recombinant interferon-alpha. J. Cell. Biochem. 39:1989;107.
33. Sing G.K., Keller J.R., Ellingsworth L.R., Ruscetti F.W. Transforming growth factor beta selectively inhibits normal and leukemic human bone marrow cell growth in vitro. Blood. 72:1988;1504.
34. Southern E.M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98:1975;503.
35. Steinberg H.N., Anderson J., Crumpacker C.S., Chatis P.A. HIV infection of the BS-1 human stroma cell line: effect on murine hematopoiesis. Virology. 193:1993;524.
36. Tiemessen C.T., Kilroe B., Martin D.J. Interleukin-4 regulation of cytokine-induced HIV1 and interleukin-8 expression in promonocytic U1 cells is concentration- and cytokine-dependent. Res. Virol. 149:1998;21.
37. Tse K.F., Hughes N.K., Gallicchio V.S. Failure to establish long-term marrow cultures from immunodeficient mice (MAIDS): effect of zidovudine in vitro. J. Leukoc Biol. 53:1993;658.
38. Tse K.F., Morrow J.K., Hughes N.K., Gallicchio V.S. Stromal cell lines derived from LP-BM5 murine leukemia virus-infected long-term bone marrow cultures impair hematopoiesis in vitro. Blood. 84:1994;1508.
39. Valentin A., Lu W., Rosati M., Schneider R., Albert J., Karlsson A., Pavlakis G.N. Dual effect of interleukin 4 on HIV-1 expression: implications for viral phenotypic switch and disease progression. Proc. Natl. Acad. Sci. USA. 95:1998;8886.
40. Valdez H., Lederman M.M., 1997. Cytokines and cytokine therapies in HIV infection, AIDS Clin. Rev. 187.
41. Weichold F.F., Zella D., Barabitskaja O., Maciejewski J.P., Dunn D.E., Sloand E.M., Young N.S. Neither human immunodeficiency virus-1 (HIV-1) nor HIV-2 infects most-primitive human hematopoietic stem cells as assessed in long-term bone marrow cultures. Blood. 91:1998;907.
42. Wilson E.L., Rifkin D.B., Kelly F., Hannocks M.J., Gabrilove J.L. Basic fibroblast growth factor stimulates myelopoiesis in long-term human bone marrow cultures. Blood. 77:1991;95.
43. Zon L.I., Arkin C., Groopman J.E. Haematologic manifestations of the human immune deficiency virus (HIV). Br. J. Haematol. 66:1987;251.